| Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins S Kim, D Kim, SW Cho, J Kim, JS Kim Genome research 24 (6), 1012-1019, 2014 | 1994 | 2014 |
| Correction of a pathogenic gene mutation in human embryos H Ma, N Marti-Gutierrez, SW Park, J Wu, Y Lee, K Suzuki, A Koski, D Ji, ... Nature 548 (7668), 413-419, 2017 | 1207 | 2017 |
| Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells D Kim, S Bae, J Park, E Kim, S Kim, HR Yu, J Hwang, JI Kim, JS Kim Nature methods 12 (3), 237-243, 2015 | 1076 | 2015 |
| In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni E Kim, T Koo, SW Park, D Kim, K Kim, HY Cho, DW Song, KJ Lee, ... Nature communications 8 (1), 14500, 2017 | 799 | 2017 |
| Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells D Kim, J Kim, JK Hur, KW Been, S Yoon, JS Kim Nature biotechnology 34 (8), 863-868, 2016 | 741 | 2016 |
| Directed evolution of CRISPR-Cas9 to increase its specificity JK Lee, E Jeong, J Lee, M Jung, E Shin, Y Kim, K Lee, I Jung, D Kim, ... Nature communications 9 (1), 3048, 2018 | 468 | 2018 |
| Genome editing reveals a role for OCT4 in human embryogenesis NME Fogarty, A McCarthy, KE Snijders, BE Powell, N Kubikova, ... Nature 550 (7674), 67-73, 2017 | 428 | 2017 |
| Highly efficient RNA-guided base editing in mouse embryos K Kim, SM Ryu, ST Kim, G Baek, D Kim, K Lim, E Chung, S Kim, JS Kim Nature biotechnology 35 (5), 435-437, 2017 | 422 | 2017 |
| Genome-wide target specificities of CRISPR RNA-guided programmable deaminases D Kim, K Lim, ST Kim, SH Yoon, K Kim, SM Ryu, JS Kim Nature biotechnology 35 (5), 475-480, 2017 | 303 | 2017 |
| Genome-wide target specificities of CRISPR-Cas9 nucleases revealed by multiplex Digenome-seq D Kim, S Kim, S Kim, J Park, JS Kim Genome research 26 (3), 406-415, 2016 | 228 | 2016 |
| Genome-wide target specificity of CRISPR RNA-guided adenine base editors D Kim, D Kim, G Lee, SI Cho, JS Kim Nature biotechnology 37 (4), 430-435, 2019 | 189 | 2019 |
| Highly efficient genome editing by CRISPR-Cpf1 using CRISPR RNA with a uridinylate-rich 3′-overhang SU Bin Moon, JM Lee, JG Kang, NE Lee, DI Ha, DY Kim, SH Kim, K Yoo, ... Nature communications 9 (1), 3651, 2018 | 176 | 2018 |
| Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration K Kim, SW Park, JH Kim, SH Lee, D Kim, T Koo, K Kim, JH Kim, JS Kim Genome research 27 (3), 419-426, 2017 | 175 | 2017 |
| Genotyping with CRISPR-Cas-derived RNA-guided endonucleases JM Kim, D Kim, S Kim, JS Kim Nature communications 5 (1), 3157, 2014 | 148 | 2014 |
| Efficient CRISPR editing with a hypercompact Cas12f1 and engineered guide RNAs delivered by adeno-associated virus DY Kim, JM Lee, SB Moon, HJ Chin, S Park, Y Lim, D Kim, T Koo, JH Ko, ... Nature biotechnology 40 (1), 94-102, 2022 | 143 | 2022 |
| Evaluating and enhancing target specificity of gene-editing nucleases and deaminases D Kim, K Luk, SA Wolfe, JS Kim Annual review of biochemistry 88, 191-220, 2019 | 138 | 2019 |
| Long terminal repeat CRISPR-CAR-coupled “universal” T cells mediate potent anti-leukemic effects C Georgiadis, R Preece, L Nickolay, A Etuk, A Petrova, D Ladon, A Danyi, ... Molecular Therapy 26 (5), 1215-1227, 2018 | 125 | 2018 |
| Unbiased investigation of specificities of prime editing systems in human cells DY Kim, SB Moon, JH Ko, YS Kim, D Kim Nucleic acids research 48 (18), 10576-10589, 2020 | 113 | 2020 |
| Application of prime editing to the correction of mutations and phenotypes in adult mice with liver and eye diseases H Jang, DH Jo, CS Cho, JH Shin, JH Seo, G Yu, R Gopalappa, D Kim, ... Nature biomedical engineering 6 (2), 181-194, 2022 | 110 | 2022 |
| DIG-seq: a genome-wide CRISPR off-target profiling method using chromatin DNA D Kim, JS Kim Genome research 28 (12), 1894-1900, 2018 | 99 | 2018 |
